Results 181 to 190 of about 1,337,922 (367)
ABSTRACT Background Apolipoprotein ε4 (APOE ε4) is a potent genetic risk factor for Alzheimer's disease (AD). However, its role in cerebral small vessel disease (CSVD) remains unclear. Given the clinical and pathological similarities between CSVD and AD, this study aimed to investigate the associations of APOE ε4 gene dosage with cognitive function and
Tingru Jin +6 more
wiley +1 more source
Safer oxygenation through flexible optical scopes during airway management: an in vitro study. [PDF]
Garioud A, Kristensen MS.
europepmc +1 more source
ABSTRACT Aims This study aimed to explore the relationship between stress‐induced hyperglycemia (SIH) and in‐hospital medical complications in patients with acute stroke. Methods We enrolled 865,765 patients with acute stroke from the Chinese Stroke Center Alliance cohort.
Xintong Song +6 more
wiley +1 more source
Numerical Analysis on Desanding Process of Swirl Nozzle in a Closed Container
In order to investigate the distribution of flow field in a container during desanding process of swirl nozzle and the influence of the flow field on the desanding capacity,RSM and DPM models were used to numerically simulate the flow field and particle ...
Wu Xiaojian +3 more
doaj
A fast sample shuttle to couple high and low magnetic fields and applications in high-resolution relaxometry. [PDF]
Villanueva-Garibay JA +16 more
europepmc +1 more source
Insights Into the Antigenic Repertoire of Unclassified Synaptic Antibodies
ABSTRACT Objective We sought to characterize the sixth most common finding in our neuroimmunological laboratory practice (tissue assay‐observed unclassified neural antibodies [UNAs]), combining protein microarray and phage immunoprecipitation sequencing (PhIP‐Seq). Methods Patient specimens (258; 133 serums; 125 CSF) meeting UNA criteria were profiled;
Michael Gilligan +22 more
wiley +1 more source
High-resolution Hi-C profiling of human breast tissues using an optimized protocol for clinical samples. [PDF]
Choppavarapu L +5 more
europepmc +1 more source
Inhibition of Classical and Alternative Complement Pathway by Ravulizumab and Eculizumab
ABSTRACT Objective To explore the feasibility of classical (CH50) and alternative (AH50) complement pathway activity as potential biomarkers for treatment guidance and monitoring during therapy with ravulizumab in patients with generalized myasthenia gravis (gMG) and compare these to therapeutic drug monitoring under eculizumab.
Lea Gerischer +14 more
wiley +1 more source

